200 Economists: “Costly protectionism should not be foisted on patients at home and abroad”

From an open letter to Mr. Trump:

A Buy America directive can also hamstring the ability of U.S. pharmaceutical and medical equipment manufacturers to meet our future needs if firms are denied access to essential foreign supplies. Moreover, we can expect our trading partners to adopt retaliatory “Don’t Buy American” barriers targeting U.S. exports as this type of retaliation is already occurring between other countries.

Continue reading

Beware of Definitive Statements

Reader Steven Kopits disputes the idea that the US per capita fatality rates can approach those of Italy:

Reporting for the day May 8, the US had the 5th highest death rate (for this day alone, not cumulatively), at 6.8 per million. Interestingly, Sweden was No. 2 at 9.7 per million.
Here’s the top fifteen in order (worst at top) of 84 countries reporting deaths today:

Continue reading

Guest Contribution: “Market volatility and the length of the Covid-19 recession”

Today, we are pleased to present a guest contribution written by Valerio Ercolani and Filippo Natoli, both of the Directorate General for Economics, Statistics and Research of the Bank of Italy. The views presented in this note represent those of the authors and not necessarily reflect those of the Bank of Italy.

 


After the economic downturn that followed the outbreak of the Covid-19 crisis, private forecasters see a rebound in the third quarter of 2020 both in the US and worldwide. While this appears as the most plausible scenario assuming lockdown and social distancing measures are soon relaxed, a recessive dynamics through the end of the year cannot be ruled out. A simple probit model augmented with market volatility, which reached its maximum last March, forecasts a more prolonged recession in the United States. Historically, turmoil in financial markets informed us that the associated recessions were not close to the end. 

Continue reading